Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.
Darlene Dobkowski, MA
Advertisement
Articles by Darlene Dobkowski, MA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
2
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
3
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
4
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
5
